Retrievable IVC filter use down, but still high considering risks

August 16, 2017 - The use of retrievable inferior vena cava, or IVC, filters has fallen since the FDA issued a safety warning in 2010 about fracture and other adverse effects linked to the devices, but the... Read More

Third Xarelto Trial Begins This Week

August 9, 2017 - Last month, U.S. District Judge Eldon E. Fallon rejected the latest attempts by Xarelto makers to dodge consumers’ efforts to hold them accountable. Judge Fallon denied the defendants’... Read More

Proton Pump Inhibitor (PPI) MDL granted

August 4, 2017 - Plaintiffs are suing PPI manufacturers after developing kidney damage linked to the use of PPIs. Studies dating back to the 1990s have linked PPIs, including Nexium, Prevacid, and Prilosec,... Read More

Rare ruling in Taxotere MDL allows claims against generics

August 2, 2017 - A recent, rare ruling by the U.S. Judicial Panel on Multidistrict Litigation (JPML) allows claims against manufacturers of generic versions of Taxotere to be included in the MDL. Read More

Recent studies confirm Xarelto bleeding risks, adverse events

July 27, 2017 - There were 21,996 severe injuries reported involving anticoagulant drugs including 3,018 reported deaths, and Xarelto was the top culprit for this class of drugs. Read More

Jury hits testosterone therapy maker AbbVie with $150 million in punitive damages

July 24, 2017 - The jury found that AbbVie fraudulently marketed AndroGel by creating a condition dubbed “Low T,” presenting the product directly to men as a kind of fountain of youth. Read More

MDL established for Physiomesh plaintiffs

July 20, 2017 - The U.S. Judicial Panel on Multidistrict Litigation created a multidistrict litigation (MDL) for claims against Physiomesh makers Ethicon and Johnson & Johnson. Read More

Risperdal legal troubles continue to mount

July 13, 2017 - The suit was filed by a number of child advocacy organizations on behalf of children in the Missouri foster care system who were “inappropriately provid[ed] psychotropic drugs” with... Read More

Proton Pump Inhibitor kidney injury claims MDL request renewed

July 6, 2017 - Evidence of adverse side effects, some life threatening, continues to grow, linking PPI use to Acute Kidney Injury (AKI or Acute Renal Failure) and Chronic Kidney Disease. Read More

Fourth Talcum Powder Trial Yields Largest Plaintiff’s Verdict

July 5, 2017 - Johnson & Johnson is facing a record-setting jury verdict – $110 million – in favor of a fourth plaintiff over the company’s failure to warn consumers about the link between its... Read More

back to top